TRMED — Thor Medical ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK688.61m
- NOK565.96m
Annual cashflow statement for Thor Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -416 | -440 | -310 | -5.56 | -42.6 |
| Depreciation | |||||
| Non-Cash Items | -28.6 | 3.96 | -11.8 | -28.2 | 1.11 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 31.6 | 21.3 | -98.1 | -31.1 | 15.2 |
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -398 | -403 | -409 | -64.1 | -24 |
| Capital Expenditures | -0.185 | -0.259 | -5.63 | — | -0.14 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.59 | 1.12 | 3.16 | 6.28 | 1.7 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.41 | 0.863 | -2.46 | 6.28 | 1.56 |
| Financing Cash Flow Items | -16.3 | -28 | -17.2 | -0.32 | -9.82 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 201 | 385 | 228 | -0.332 | 104 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -177 | -16.3 | -179 | -56.9 | 81.6 |